This could potentially aid individuals in preserving mobility during weight loss or fitness programs
In the digital age, data is the new oil and information technology is the machinery that extracts, refines and powers the engine of progress
Not for human consumption, diagnostic, or clinical use
Activity Restrictions: Refrain from strenuous activities, including cardio and strength training, for the first two weeks after the procedure
Once the procedure is completed, absorbent pads are placed on the incision points and a compression garment is fitted
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise